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Second primary cancer and inﬂuencing factors
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Introduction. Today the term of second primary cancer is used to refer to cancers that occurred in survivors, themselves associated
with cancer therapies, exposure to risk factors or the presence of genetic alterations, becoming very frequent up to 16% of the
overall incidence according to the SEER.
Objective. The SCP are a growing gun seems relevant interest and present a series of cases in order to review this topic.
Materials and methods. Observational and descriptive carriers SCP 159 cases treated in our department from a sample of 5184
patients.
Results. Collect 5184 patients in our databasewith ameanage of 64.6 years being the 62.7%menand 37.3%womenandwhosemost
frequent primary tumor were breast (22.8%), prostate (21.4%), chest (14.1%), and gastrointestinal (12.5%). Of these patients, we
selected those with a second primary tumor whose average age is 69 years, 67.9% men and 32.1% women and following locations:
prostate (23.9%), breast (18.9%), bladder (7.5%), chest (7.5%) and digestive (3.1%) being the most common sites of second primary
cancers: Chest (22.6%), digestive (10.1%), prostate (8.8%), breast (14.5%) and larynx (8.2%). If we compare the locations observed
no signiﬁcant correlation (Spearman) (P: 0.666) If we analyze the time between tumors get an average of 7.34 years, median 6
years and 2 years fashion with Dev. Tip variance of 6.83 and 46.69, the correlation between the location of the second tumor
and the time of onset no signiﬁcant differences (P: 0.419). No correlation between radiation therapy and occurrence of a second
tumor (P: 0.804).
Conclusion. Despite improvements in treatment and early diagnosis, suffering a second tumor remains a challenge in research.
Our results argue that both age, gender, location, time and radiation therapy to the site of the ﬁrst tumor, are factors affecting
development of this.
http://dx.doi.org/10.1016/j.rpor.2013.03.397
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Background. These goals of conformal radiotherapy techniques are threatened by the geometrical uncertainties inherent in
radiotherapy planning and execution processes.
Aim. To quantify systematic () and random () set-up errors in a single radiation therapy center.
Materials and methods. This prospective study was conducted for consecutive patients treated with radiation therapy from August
2010 through August 2012. Veriﬁcation electronic portal images of orthogonal set-up ﬁelds were obtained daily for the initial 3–5
consecutive fractions for 186 patients treated for prostate (N=64), breast (N=62), rectal (N=25), head and neck (N=21), and lung
(N=14) cancer. The calculated systematic error was used to shift the isocentre accordingly on the third/ﬁfth treatment day. From
then until the end of the treatment course, pair orthogonal portal images of set-up ﬁelds were obtained weekly. Margins were
calculated using the Stroom formula (2+0.7).
Results. For all patients, margin according Stroom equation were: 5.3mm for the lateral (X) axis, 4.0mm for the longitudinal (Y)
axis, and 6.0mm for the vertical (Z) axis. Mean displacements for the Z axis (2.9mm) were signiﬁcant higher than those for the X
(2.3mm; t-Student p=0.02) and Y axes (1.7mm; t-Student p=0.01). There was a signiﬁcant difference in the mean displacements
for the Y axis (p=0.032) among pathologies. Breast and rectal cancer patients had higher mean displacements for the Y axis
(2.4mm and 3.4mm, respectively) than the rest of patients.
Conclusion. Mean displacements for the Z axis were signiﬁcant higher than those for the X and Y axes. Breast and rectal cancer
patients had higher mean displacements for the Y axis. Serial portal imaging enables to calculate and control of systematic set-
up errors for patients treated with modern techniques of radiation therapy what makes possible to assess customized planning
tumor volume margins.
http://dx.doi.org/10.1016/j.rpor.2013.03.398
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Introduction. Historically, systemic lupus erythematosus (SLE) has been considered as a relative contraindication for radiotherapy
(RT) because of the risk of greater complications. Consequently, RT may be underused for fear of severe toxicity. Despite of this
increased risk in connective disorders showed in several reports, different studies have shown signiﬁcant toxicity in a minority
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of patients. Recent reviews support these ﬁndings. Moreover, most of studies report inconsistent and controversial results as SLE
is usually included with other disorders. We communicate the acute and chronic toxic effects of radiotherapy in a patient with
SLE.
Materials and methods (case report). A 45-year-old woman, with SLE and a history of chronic renal insufﬁciency, hepatitis C virus,
kidney transplant, and several acute exacerbation episodes, was treated with standard radiation treatment for breast cancer
(ductal, T1N0M0). The patient underwent 30 courses of external beam RT to the right breast and tumor bed (total dose 60Gy).
The patientwas seen several times during the treatment. Therewere four check-ups,with pictures at the ﬁrstweek, at completion
of treatment, and 6 months later. Toxicity was evaluated using the common toxicity criteria for adverse event v3.0.
Results. No high toxicity was reported ﬁfteen days since the beginning and 6 months after radiotherapy. Only at completion of
radiotherapy, grade 3 toxicity (erythema with moist desquamation) was observed, that persisted for a month. The patient has
not had any clinical exacerbation. No treatment courses were interrupted. The patient does not suffer from severe late radiation
complications, with a follow-up of 6 months.
Conclusions. SLE should not be an absolute contraindication to radiotherapy, which could be cautiously offered to patients with
malignant disease.More studies should exclusively examine adverse effects of radiotherapy for patientswith different connective
disorders.
http://dx.doi.org/10.1016/j.rpor.2013.03.399
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Background. Glomus are uncommon benign tumors. Treatment options are resection and radiotherapy. These tumors usually
were treated using conventional RT 3D with 10–15mm margins. Technical innovation allows to cover target volume with narrow
margins. Since 2002 in our institution we use fractionated stereotactic radiation therapy (FSRT) in these tumors.
Purpose. We analyze local control, clinical response and toxicity in patients treated with new techniques.
Methods and materials. Between March 2002 and January 2013, 16 glomus were treated. 13 patients with FSRT and 3 with tomother-
apy.Median follow-upwas 31months (range: 6–66.5).Median agewas 60 years (range: 46–81). 12womenand 4men.Most common
symptoms were tinnitus (13p) and injury lower cranial nerves (9p). Location: 87.5% jugular and tympanic. 93.8% unilateral. 43.8%
had surgical resection previously. Median glomus size was 30mm (range: 10–70) and median target volume was 21.3 cm3 (range
6.37–464.2). Median margins added to the gross tumor volume (GTV) to generate planning target volume (PTV) was 3mm (range
2–10). The median total dose was 50.4Gy (1.8Gy per fraction) at 95% PTV coverage. Median conformity index in FSRT was 1.2
(range: 1.18–1.47).
Results. No patients developed exacerbated symptoms or new neurological complications. 50% improved tinnitus and hearing.
No cases of clinical or radiological progression were identiﬁed. 63.7% of tumors were stable and 37.3% showed size reduction.
Conclusion. FSRT and tomotherapy are effective and safe therapies for patients with glomus. High local control rates associated
with very low incidence of side effects were achieved. This treatment may be used in many patients as an alternative to surgical
resection.
http://dx.doi.org/10.1016/j.rpor.2013.03.400
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Background and purpose. Thekeloid is deﬁnedas a scar inwhichﬁbrous or connective tissue elements of the coriumhaveundergone
hyperplasia. The aim of this study is to evaluate the response of keloids treated with surgical excision, suture and postoperative
radiotherapy. Patients were irradiated within 24h after surgery for three alternate days.
Materials and methods. We report data from twenty-nine patients (thirteen women and six men), mean age 41 years (range from
ten to seventy-two years old), followed-up between 1995 and 2012. Twenty-seven patients were Caucasian, and two of them were
dark skinned, because the incidence of keloids among this group is higher. Three patients were treated with low kilovoltage
X-ray therapy, twenty-six patients received electron beam irradiation and two patients were treated with brachytherapy. The
median dosage did not vary to a signiﬁcant degree. Seventeen patients received a total dose of 15Gy in three alternate days. In
some patients the dosage varied in a small degree, but always keeping three fractions in alternate days. Two patients with ear
lobe keloids were treated using brachythrapy in alternate days. We assume the necessity of preceding keloidectomy, previous to
radiation therapy, and the necessity to treat within 24h after keloid excision.
Results. The results of our treatment using low X-ray energy were similar to using an electron beam treatment. We conclude
that excision and early postoperative irradiation constitute effective keloid treatment. The overall success rate (good or excellent
